Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-002471

General Counsel acquired 658 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Adams Brian General Counsel 2021-12-31 Grant or award +658 $26.10 $17,174 25,647 D
Loading xslF345X03/doc4.xml…